Artelo Biosciences, Inc. (ARTL) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 3 institutional investors hold a position in Artelo Biosciences, Inc. (NASDAQ:ARTL).

• The percentage of Artelo Biosciences owned by institutions changed from 4.2% in September 2025 to 6.1% in December 2025, marking a slight up trend.
• Quarterly data indicates a 234.69% shift in institutional share volume, and the annual owner count reflects a decrease of 50.00%.
• The latest 13F cycle for Artelo Biosciences reveals that of 3 total investors, 2 funds grew their exposure, whereas 0 reduced theirs and 1 made no changes.
• This class of investors increased its holdings in Artelo Biosciences to 47.65K shares for the 13F-cycle ending December 2025, up by 33.41K shares quarter on quarter, and up 13.14K shares year over year.
• UBS Group AG continues to be the largest institutional holder of Artelo Biosciences as of December 31, 2025, with a position of 33.62K shares, representing 4.28% of the company's outstanding stock.
• Among the most significant buyers of Artelo Biosciences during December 2025 were UBS Group AG (33.41K), CWM, LLC (1).
• The top 3 institutional holders of Artelo Biosciences for the quarter ending December 2025 included UBS Group AG (33.62K), VANGUARD GROUP INC (14.03K), CWM, LLC (1).